Hepatic iron deposition on magnetic resonance imaging: Correlation with inflammatory activity

Journal of Computer Assisted Tomography

Volumn 26, Issue 6, 2002, Pages 988-993

  Kim, Myeong Jin ^a   Mitchell, Donald G ^b   Ito, Katsuyoshi ^c   Kim, Joo Hee ^a   Pasqualin, Denise ^b   Rubin, Raphael ^b  

^a Yonsei University College of Medicine   (South Korea)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^c YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatitis; Iron overload; Liver cirrhosis?; Liver diseases; Magnetic resonance imaging

Indexed keywords

DEPOSITION; GRADING; MAGNETISM; PATHOLOGY; RESONANCE;

ECHO MAGNETIC RESONANCE; GRADIENT ECHO; HEPATITIS; INFLAMMATORY ACTIVITY; IRON DEPOSITION; IRON OVERLOADS; LIVER CIRRHOSIS; LIVER CIRRHOSIS?; LIVER DISEASE; T2 WEIGHTED;

MAGNETIC RESONANCE IMAGING;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IRON BLOOD LEVEL; IRON OVERLOAD; LIVER CIRRHOSIS; LIVER HEMOSIDEROSIS; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIGNAL PROCESSING;

EID: 0036871553     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-200211000-00023     Document Type: Article

References (35)

1. Prieto J, Barry M, Sherlock S. Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology 1975;68:525-33.
2. Adams PC. Iron overload in viral and alcoholic liver disease. J Hepatol 1998;28:19-20.
3. Ludwig J, Hashimoto E, Porayko MK, et al. Hemosiderosis in cirrhosis: A study of 447 native livers. Gastroenterology 1997;112:882-8.
4. Cotler SJ, Bronner MP, Press RD, et al. End-stage liver disease without hemochromatosis associated with elevated hepatic iron index. J Hepatol 1998;29:257-62.
5. Deugnier Y, Turlin B, le Quilleuc D, et al. A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: Practical implications for the diagnosis of hemochromatosis. Am J Surg Pathol 1997;21:669-75.
6. Turlin B, Deugnier Y. Evaluation and interpretation of iron in the liver. Semin Diagn Pathol 1998;15:237-45.
7. Terada T, Nakanuma Y. Survey of iron-accumulative macroregenerative nodules in cirrhotic liver. Hepatology 1989;10:851-4.
8. Hengeveld P, Zuyderhoudt FMJ, Jobsis AC, et al. Some aspects of iron metabolism during acute viral hepatitis. Hepatogastroenterology 1982;29:138-41.
9. Scheurer P. Viral hepatitis. In: MacSween R, Anthony P, Scheuer P, eds. Pathology of the Liver. London: Churchill Livingstone, 1988:203-210.
10. Boucher E, Bourienne A, Adams P, et al. Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment. Gut 1997;41:115-20.
11. Bonkovsky HL, Banner BF, Rothman AL. Iron and chronic viral hepatitis. Hepatology 1997;25:759-68.
12. Deugnier Y, Battisteelli D, Jouanolle H, et al. Hepatitis B virus infection markers in genetic haemochromatosis. A study of 272 patients. J Hepatol 1991;13:286-90.
13. Zhou X, DeTolla L, Custer P, et al. Iron ferritin, hepatitis B surface and core antigens in the livers of Chinese patients with hepatocellular carcinoma. Cancer 1987;59:1430-7.
14. Bomford AB, Munro HN. Transferrin and its receptor: Their roles in cell function. Hepatology 1985;5:870-5.
15. Johnston DL, Rice L, Vick GW, et al. Assessment of tissue iron overload by nuclear magnetic resonance imaging. Am J Med 1989;87:40-7.
16. Bonkovsky HL, Slaker DP, Bills EB, et al. Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage diseases. Gastroenterology 1990;99:1079-91.
17. Guyader D, Gandon Y, Robert JY, et al. Magnetic resonance imaging and assessment of liver iron content in genetic hemochromatosis. J Hepatol 1992;15:304-8.
18. Rocchi E, Cassanelli M, Borghi A, et al. Magnetic resonance imaging and different levels of iron overload in chronic liver diseases. Hepatology 1993;17:997-1002.
19. Gandon Y, Guyader D, Heautot JF, et al. Hemochromatosis: Diagnosis and quantification of liver iron with gradient-echo MR imaging. Radiology 1994;193:533-8.
20. Ernst O, Sergent G, Bonvarlet P, et al. Hepatic iron overload: Diagnosis and quantification with MR imaging. AJR Am J Roentgenol 1997;168:1205-8.
21. Siegelman ES, Mitchell DG, Semelka RC. Abdominal iron deposition: Metabolism, MR findings, and clinical importance. Radiology 1996;199:13-22.
22. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histologic activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
23. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994;19:1513-20.
24. Batts KP, Ludwig J. Chronic hepatitis: An update on terminology and reporting. Am J Surg Pathol 1995;19:1409-17.
25. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
26. Marti-Bonmati L, Talens A, del Olmo J, et al. Chronic hepatitis and cirrhosis: Evaluation by means of MR imaging with histologic correlation. Radiology 1993;188:37-43.
27. Beinker NK, Voigt MD, Arendse M, et al. Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C. J Hepatol 1996;25:633-8.
28. Aldouri MA, Wonke B, Hoffbrand AV, et al. Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine. J Clin Pathol 1987;40:1353-9.
29. Bacon BR. Iron and hepatitis C. Gut 1997;41:127-8.
30. Van Thiel DH, Friedlander L, Fagiuoli S, et al. Response to interferon [alpha] therapy is influenced by the iron content of the liver. J Hepatol 1994;20:410-5.
31. Barton AL, Banner BF, Cable EE, et al. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy. Am J Clin Pathol 1995;103:419-24.
32. Pugh RNH, Murray-Lyon IM, Dawson JL, et al. Transsection of the esophagus for bleeding esophageal varices. Br J Surg 1973;60:646-9.
33. de Jongh FE, Janssens HLA, de Man RA, et al. Survival and prognostic indicators in HbsAg-positive cirrhosis of the liver: The role of HbeAg seroconversion. Gastroenterology 1992;103:1630-5.
34. Hoofnagle JH, Di Bisceglie AM, Waggoner JG, et al. Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B. Gastroenterology 1993;21:151-4.
35. Ito K, Mitchell DG, Hann HW, et al. Progressive viral-induced cirrhosis: Serial MR imaging findings and clinical correlation. Radiology 1998;207:729-35.